Daily non-political popular news in brief.

NEJM report on cardiac emergency therapy finds single medication effective vs. combination drugs

A study published in the New England Journal of Medicine led by Columbia University Medical Center and New York-Presbyterian Hospital researchers showed that an anti-clotting agent called bivalirudin, when used by itself to treat acute coronary syndromes, reduced the risk of major bleeding, a key risk for mortality, by 47 percent compared with the standard combination drugs. The medication was found to be equally as effective as the combination of injectable blood thinners traditionally used.

Read more »

Keywords: nejm, report, cardiac, emergency, therapy, single, medication, effective, combination, drugs, drug

« Previous | Next »

Similar news on "NEJM report on cardiac emergency therapy finds single medication effective vs. combination drugs":

1. Combination therapy appears more effective than single drug for lower urinary tract symptoms
   11-14-2006 · EurekAlert!
   Men with overactive bladder and lower urinary tract symptoms who received a combination therapy were more likely to report improvement in symptoms than men who received only one medication, according to a study in the Nov. 15 issue of JAMA, a theme issue on men's health.
   Similar news · Read more »
   
2. Combination of medication and psychotherapy appears most effective for treatment of depressed teens
   10-01-2007 · EurekAlert!
   The combination of the antidepressant medication fluoxetine and cognitive behavior therapy appears more effective than either strategy alone for the long-term treatment of adolescents with depression, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
   Similar news · Read more »
   
3. Drug combination proves effective against myeloma in Phase I trial
   12-11-2006 · EurekAlert!
   Two "new generation" drugs for the bone marrow cancer multiple myeloma may work even better together than they do individually, according to the results of a multicenter Phase I clinical trial to be presented by Dana-Farber Cancer Institute scientists at the annual meeting of the American Society of Hematology in Orlando, Fla.
   Similar news · Read more »
   
4. One-fifth of patients in drug-free remission following early treatment with Infliximab and Methotrex
   06-14-2007 · EurekAlert!
   Early treatment with a combination of methotrexate and infliximab may be effective as remission induction therapy and alter the course of early rheumatoid arthritis, according to data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
   Similar news · Read more »
   
5. HIV drug resistance risk in mothers reduced by combination of common drugs
   11-09-2007 · EurekAlert!
   Adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs, potentially improving future treatment options.Providing tenofovir and emtricitabine with nevirapine during labor greatly reduces the extent of resistance to non-nucleoside reverse transcriptate inhibitors, such as nevirapine, which HIV-positive women take to lower the risk of mother-to-child transmission during childbirth.
   Similar news · Read more »
   
6. Drug and procedural interventions offer better quality of life
   03-26-2007 · EurekAlert!
   Emergency and nonemergency care of cardiovascular disease have continually improved over the past decade, thanks to improved quality of care, novel procedures and better therapies. Research on improved care of cardiovascular disease shows improvements with a combination of drug and risk factor interventions. Three studies presented today at the American College of Cardiology's 56th Annual Scientific Session assess how continued improvements in cardiac care can lead to enhanced clinical practice and improved quality of life.
   Similar news · Read more »
   
7. New data reveal pregnancies exposed to accutane despite risk management program
   07-31-2007 · EurekAlert!
   More than 120 pregnancies were exposed during the first year of iPledge, a mandatory program designed to prevent pregnant women from being exposed to the anti-acne medication Accutane and similar medications containing isotretinoin (a known teratogen or birth defect-causing agent), a report revealed. The Food and Drug Administration's Dermatologic and Ophthalmic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee will discuss the report's findings Aug. 1
   Similar news · Read more »
   
8. 1/5 of patients in drug-free remission following early treatment with Infliximab and Methotrex
   06-14-2007 · EurekAlert!
   Early treatment with a combination of methotrexate and infliximab may be effective as remission induction therapy and alter the course of early rheumatoid arthritis, according to data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
   Similar news · Read more »
   
9. Firefly genes allow testing of new therapy against lymphoma
   12-19-2007 · EurekAlert!
   Researchers here have figured out a way to use a firefly gene to let them see just how effective a new drug combination actually is against some forms of cancer and its serious complication. The new study looked at ATLL, adult T cell lymphoma and leukemia, a form of cancer where it is particularly hard to gauge the disease's progress, and where the patients' prognosis is generally poor. There is now no widely effective therapy available to treat this disease successfully.
   Similar news · Read more »
   
10. Effectiveness of first renin inhibitor drug for treating hypertension is limited
    05-09-2007 · EurekAlert!
    Hypertension is a serious condition affecting millions. There are seven classes of drugs used to reduce blood pressure. Aliskiren is the first of a new class of antihypertensive drugs that works by inhibiting renin. A review of six large clinical trials of aliskiren is being published in the May issue of the American Journal of Hypertension. The authors report that, because of reactive renin secretion, this drug has not been any more effective than those already widely available.
    Similar news · Read more »